Skip to main content

Statin Therapy at Discharge after Lower Extremity Bypass (LEB)

CBE ID
1519
Endorsement Status
Endorsement Removed
E&M Committee Rationale/Justification

Steward no longer seeking to maintain endorsement

1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2015
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 years and older undergoing infrainguinal lower extremity bypass who are prescribed a statin medication at discharge. This measure is proposed for both hospitals and individual providers.

    • 1.14 Numerator

      Patients undergoing infrainguinal lower extremity bypass who are prescribed a statin medication at discharge.

    • 1.15 Denominator

      All patients aged 18 years and older undergoing lower extremity bypass as defined above who are discharged alive, excluding those patients who are intolerant to statins.

    • Exclusions

      Chart documentation that patient was not an eligible candidate for statin therapy due to known drug intolerance, or patient died before discharge.

    • 1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Endorsed Surgery Project 2015-2017
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Society for Vascular Surgery
      Steward Organization POC Email
      [email protected]
    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off